Latest Breaking News On - Jarrod longcor - Page 1 : comparemela.com

Cellectar Biosciences, Inc (NASDAQ:CLRB) Q1 2024 Earnings Call Transcript

Cellectar Biosciences, Inc (NASDAQ:CLRB) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesAndrei shustovJim carusoShane leaJames carusoJarrod longcorJeff jonesJonathan aschoffAmerican oncology networkLadenburg thalmannCellectar biosciences incCellectar biosciencesCall transcript mayCellectar biosciences first quarterPrivate securities litigation reform actInvestor relations

Cellectar Biosciences, Inc (NASDAQ:CLRB) Q4 2023 Earnings Call Transcript

Operator: Good morning. And welcome to Cellectar Biosciences 2023 Yearend Earnings Call. Today s call is being recorded.

United statesUniversity of wisconsinJim carusoEric gustafsonAlison bautistaShane leaJarrod longcorJonathan aschoffCellectar biosciencesAndrei shustovCellectar biosciences incDrug administrationAmerican oncology networkWisconsin alumni research foundationCall transcript marchPrivate securities litigation reform act

Cellectar Biosciences, Inc (NASDAQ:CLRB) Q3 2023 Earnings Call Transcript

Operator: Good morning, and welcome to Cellectar Biosciences Third Quarter 2023 Update Call. Today s conference is being recorded.

United statesJarrod longcorMonique kosseJonathan aschoffShane leaJim carusoAndrei shustovJames carusoCellectar biosciences incCellectar biosciencesCall transcript novemberCellectar biosciences third quarterChad koleanChief financial officerChief operating officerChief commercial officer

Cellectar Reports Financial Results for Second Quarter 2023

FLORHAM PARK, N.J., Aug. 14, 2023 (GLOBE NEWSWIRE) Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage biopharmaceutical company focused on the.

United statesJarrod longcorMonique kosseJames carusoCellectar biosciencesCellectar biosciences incExchange commissionSociety of nuclear medicineDevelopment expenseTherapeutic area partnership oncologyRecent corporateNuclear medicineMolecular imaging annualTherapeutic area partnershipCash equivalentsAdministrative expense

Cellectar Biosciences: Cellectar Reports Financial Results for Second Quarter 2023 and Provides a Corporate Update

Cellectar Biosciences: Cellectar Reports Financial Results for Second Quarter 2023 and Provides a Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesJames carusoMonique kosseJarrod longcorCellectar biosciencesCellectar biosciences incDevelopment expenseSociety of nuclear medicineTherapeutic area partnership oncologyExchange commissionRecent corporateNuclear medicineMolecular imaging annualTherapeutic area partnershipCash equivalentsAdministrative expense